Key trials in Huntington’s disease: SAGE-718, pridopidine, PTC518, & ANX005
In this week’s episode, specialists in the Huntington's disease (HD) field discuss the details of major ongoing studies and give an insight into the implications that their research could have for dis...
19 Loka 202220min
New horizons in hyperkinetic movement disorders
In this podcast, Sanjay Pandey, MD, Govind Ballabh Pant Hospital, New Delhi, India; Carlo Colosimo, MD, FEAN, Santa Maria University Hospital, Terni, Italy; and Marcelo Kauffman, MD, PhD, Hospital JM ...
13 Loka 202212min
Update on cenobamate: long-term and subgroup analyses
Cenobamate was approved by the FDA in 2019 and the EMA in 2021 for the adjunctive treatment of focal-onset seizures with or without secondary generalization in adult patients. Following its approval, ...
7 Loka 202226min
Novel targets for therapeutic intervention in movement disorders
In this episode, Serge Przedborski, MD, PhD, Columbia University Irving Medical Center, New York, NY; Marina Romero-Ramos, PhD, Aarhus University, Aarhus, Denmark; and Tiago Outeiro, PhD, University M...
30 Syys 202211min
Improving ALS management: diagnosis and treatment
In this podcast, Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMS, University of Sydney, Sydney, Australia; and Nigel Leigh, MBBS, PhD, FRCP, FAAN, FMedSci, University of Sussex, Brighton, UK, discuss cr...
9 Syys 202212min
Broadening the use of thrombectomy in stroke management
In this podcast, experts discuss the current controversies surrounding the application of endovascular thrombectomy in stroke management and present developments in research regarding patient selectio...
1 Syys 202215min
Complement inhibitors and FcRn antagonists for myasthenia gravis
In this episode, James F. Howard, Jr., MD, FAAN, University of North Carolina School of Medicine, Chapel Hill, NC, discusses the results from the open-label extensions of the CHAMPION MG trial (NCT039...
19 Elo 202216min
Novel imaging biomarkers in multiple sclerosis
Experts discuss novel imaging biomarkers in multiple sclerosis and efforts to drive these tools into clinical practice. Jaume Sastre-Garriga, MD, PhD; Vall d'Hebron University Hospital, Barcelona; Pas...
18 Elo 202220min
